This contract expires in 247 days (Jun 30, 2027).

Browse related active opportunities

IQ SOLUTIONS, INC. - CDER PHASE II FOR BIOSIMILARS EDUCATION AND OUTREACH INITIATIVE

PIID: 75F40126F80077
Signed Date: Jun 25, 2026Effective Date: Jul 1, 2026End Date: Closes in 247 days
Award $
$350K
Vendor
IQ SOLUTIONS, INC.
NAICS
541613
Signed Date
Jun 25, 2026

Key Details

Dollars Obligated
$349,769.64
Base & All Options
$1.9M
Awarding Sub-Agency
Food and Drug Administration
Contract Vehicle
GSA MAS (legacy)
Parent IDIQ (PIID)
GS00F083CA
Product Service Code
B542 - SPECIAL STUDIES/ANALYSIS- EDUCATIONAL
Extent Competed
FULL AND OPEN COMPETITION
Number of Offers
6
Place of Performance
SILVER SPRING, MD

Description

CDER PHASE II FOR BIOSIMILARS EDUCATION AND OUTREACH INITIATIVE

Context & Analysis

On Jun 25, 2026, Department of Health and Human Services obligated $349,769.64 to IQ SOLUTIONS, INC. for cder phase ii for biosimilars education and outreach initiative. The award is classified under NAICS 541613 — MARKETING CONSULTING SERVICES. Competition extent: full and open competition with 6 offers received. Performance is located in SILVER SPRING, MD. The contract is scheduled through Jun 30, 2027 — approximately 8 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541613 — related awards are listed below.

Contractor Information

Contractor: IQ SOLUTIONS, INC.
UEI: HKS1BN6QXJ95
Location: NORTH BETHESDA, MD

Stay Updated

Get notified about new opportunities matching your interests.

Related